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In this study, gelatin-based 3D conduits with three different microstructures (nanofibrous, macroporous
and ladder-like) were fabricated for the first time via combined molding and thermally induced phase
separation (TIPS) technique for peripheral nerve regeneration. The effects of conduit microstructure
and mechanical properties on the transdifferentiation of bone marrow-derived mesenchymal stem cells
(MSCs) into Schwann cell (SC) like phenotypes were examined to help facilitate neuroregeneration and
understand material-cell interfaces. Results indicated that 3D macroporous and ladder-like structures
enhanced MSC attachment, proliferation and spreading, creating interconnected cellular networks with
large numbers of viable cells compared to nanofibrous and 2D-tissue culture plate counterparts. 3D-
ladder-like conduit structure with complex modulus of 0.4  106 Pa and pore size of 150 mm provided
the most favorable microenvironment for MSC transdifferentiation leading to 85% immunolabeling of
all SC markers. On the other hand, the macroporous conduits with complex modulus of 4  106 Pa
and pore size of 100 mm showed slightly lower (65% for p75, 75% for S100 and 85% for S100bmark-
ers) immunolabeling. Transdifferentiated MSCs within 3D-ladder-like conduits secreted significant
amounts (2.5 pg/mL NGF and 0.7 pg/mL GDNF per cell) of neurotrophic factors, while MSCs in macro-
porous conduits released slightly lower (1.5 pg/mL NGF and 0.7 pg/mL GDNF per cell) levels. PC12 cells
displayed enhanced neurite outgrowth in media conditioned by conduits with transdifferentiated MSCs.
Overall, conduits with macroporous and ladder-like 3D structures are promising platforms in transdiffer-
entiation of MSCs for neuroregeneration and should be further tested in vivo.
Statement of Significance
This manuscript focuses on the effect of microstructure and mechanical properties of gelatin-based 3D
conduits on the transdifferentiation of mesenchymal stem cells to Schwann cell-like phenotypes. This
work builds on our recently accepted manuscript in Acta Biomaterialia focused on multifunctional 2D
films, and focuses on 3D microstructured conduits designed to overcome limitations of current strategies
to facilitate peripheral nerve regeneration. The comparison between conduits fabricated with nanofi-
brous, macroporous and ladder-like microstructures showed that the ladder-like conduits showed the
most favorable environment for MSC transdifferentiation to Schwann-cell like phenotypes, as seen by
both immunolabeling as well as secretion of neurotrophic factors. This work demonstrates the impor-
tance of controlling the 3D microstructure to facilitate tissue engineering strategies involving stem cells
that can serve as promising approaches for peripheral nerve regeneration.
 2017 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.1. Introduction
The application of cell-based nerve regeneration therapies, has
been considered as a promising strategy for the treatment of large
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myelin sheath around peripheral axons, produce extracellular
matrix (ECM) molecules, integrins and trophic factors, such as
NGF (nerve growth factor), BDNF (brain-derived neurotrophic fac-
tor), and GDNF (glial cell line-derived neurotrophic factor), to
enhance guidance and support for regenerating axons. Therefore,
SCs are considered an integral component of cell-based nerve
regeneration therapies for peripheral nerve regeneration [1–9].
Although a number of studies have demonstrated enhanced axonal
regeneration across nerve gaps using nerve conduits implanted
with SCs [10–14], the limited availability, donor site morbidity
and the slow in vitro growth of SCs restricts the clinical translation
of this strategy [15]. As an alternative, in a few recent studies,
in vitro differentiated mesenchymal stem cells (MSCs) possessing
SC like properties have been explored in different types of conduits
for nerve regeneration purposes [16–19].
Mesenchymal stem cells, isolated and derived from various con-
nective tissue sources (e.g., bone marrow, adipose tissue, placenta,
umbilical cord blood) [7], hold considerable potential for cell-based
nerve regeneration therapies using autologous transplantation due
to accessibility, plasticity, multipotent nature, differentiation abil-
ity into functional cell types, paracrine activity via secretion of
bioactive molecules including neurotrophic factors such as, NGF,
BDNF and GDNF [20,21] and lack of ethical concerns [15,22–27].
Among those sources, bone marrow-derived MSCs are considered
as the most available cell type and designated as the gold standard,
although MSCs derived from other sources (adipose tissue, pla-
centa, umbilical cord blood etc.) have also shown promising poten-
tial for proliferation and differentiation into different cell types
[28]. Various studies have suggested strategies for neuronal differ-
entiation and in vivo transplantation of MSCs in order to treat
peripheral nerve damage [29–32] and numerous benefits of using
transdifferentiated MSCs have been reported including promotion
of axonal regeneration, reduced lesion size, enhanced neuronal
survival and improved functional outcomes [33–40]. The benefits
of MSC differentiation for Wallerian degeneration and nerve regen-
eration also include superior in vivo viability, enhanced neu-
rotrophic factor secretion and myelinating ability [41]. However,
current difficulties in controlling the final fate of the implanted cell
population and providing scalable differentiation protocols along
with an ideal 3D matrix mimicking the ECM, limit the clinical
use of MSCs [42,43]. The positive effects of undifferentiated MSCs,
circumventing the limitations of differentiation procedures and
clinical applicability, have also been reported. However, the trans-
plantation of undifferentiated cells may cause in vivo differentia-
tion of MSC into unwanted and non-neural cell lineages in
response to local stimuli or other dominant cells in the area [41].
The differentiation of MSCs depends on multiple interacting
factors in their microenvironment, including biological, chemical
and physical cues which, in combination, result in a complicated
differentiation behavior outcomes [44–51]. Recently, specific com-
position of the differentiation media, as well as mechanical proper-
ties of the ECM, such as structure, composition and elasticity, have
been demonstrated to influence MSC differentiation [50,52–55].
For instance, matrix stiffness has been found to regulate the differ-
entiation of MSCs into specific lineages indicating that softer sub-
strates promote neurogenic, adipogenic and chondrogenic fates,
while stiffer substrates enhance myogenesis and osteogenesis
[45,51,56–61]. The dimension in which cells are cultured is also a
crucial factor in determining the differentiation properties of the
cells. The current understanding of most biological mechanisms,
including differentiation, has been garnered from cells cultured
on two-dimensional (2D) surfaces. Most studies examining MSC
transdifferentiation have relied on 2D tissue culture plates, after
which the cells are then seeded into various types of scaffolds for
facilitating neural regeneration, leading to extra treatment steps,time, effort and cost [16,17,20,21]. The cells naturally exist in a
complex ECM containing various components, mixed cell popula-
tions and cell-secreted factors, hence, employing a 3D culture
model is more relevant to the physiological condition to explore
cell-cell and cell-matrix interactions affecting transdifferentiation.
Current knowledge with respect to the influences of mechanical
and structural properties of 3D scaffolds on the transdifferentiation
behavior of MSCs is significantly limited and should be expanded
[62]. Most of the previous studies investigated the effect of matrix
properties on the osteogenic differentiation of MSCs; on the other
hand, only a few studies focused on the relationship between
matrix properties and the differentiation of MSCs into SC like phe-
notypes [56,63–66].
Taking these motivations into account, in this study, gelatin
based 3D porous conduits with ladder-like (LL), macroporous
(MP) and nanofibrous (NF) structures were developed in order to
directly transdifferentiate bone marrow-derived MSCs into SC-
like phenotypes within the conduits for the treatment of large
peripheral nerve gaps. This strategy was used to enhance the direc-
ted transdifferentiation of MSCs within a 3D conduit matrix and
prevent unnecessary additional steps involving transdifferentia-
tion in regular 2D cultures followed by implantation. Combined
molding and thermally induced phase separation (TIPS) techniques
were selected to manufacture different microstructured 3D matri-
ces which are difficult to achieve by current electrospinning and
self-assembly techniques [67,68]. The effects of conduit structure,
morphology and mechanical properties on differentiation and
paracrine activity of MSCs (secretion of neurotrophic factors such
as NGF, BDNF and GDNF) were investigated, and the performance
of 3D conduits were compared with their 2D cell culture plate
counterparts. The paracrine activity of transdifferentiated MSCs
in the conduits was assessed not only by detecting the released
neurotrophic factors but also by measuring their biological activity
through the evaluation of neurite extension on PC12 cells co-
cultured with the MSCs across a porous membrane insert. The
overall results indicated that the conduits prepared in this study
with controlled structural properties can serve as promising candi-
dates for 3D ECM platforms intended for nerve regeneration appli-
cations and can be further tested in vivo.2. Material and methods
2.1. Materials
Type B gelatin from bovine skin, 1-ethyl-3-(3-dimethyl-
aminopropyl) carbodiimide HCl (EDC), N-hydroxysuccinimide
(NHS), (2-(N-morpholino) ethanesulfonicacid) hydrate (MES),
Bovine serum albumin (BSA), all-trans-retinoic acid (ATRA) and
b-mercaptoethanol (BME) were obtained from Sigma Aldrich. 1,
4-dioxane, acetone, ethanol were obtained from Merck. The cell
culture media components, minimum essential medium (a-
MEM) and L-glutamine were obtained from Gibco. Fetal bovine
serum (FBS) was purchased from Atlanta Biologicals and
antibiotic-antimycotic was obtained from Invitrogen. The transdif-
ferentiation components forskolin (FSK) and heregulin b1 (HRG)
were purchased from EMDMillipore, while platelet derived growth
factor (PDGF) and basic fibroblast growth factor (bFGF) were
obtained from Sigma and Promega, respectively. Triton X-100
and paraformaldehyde were supplied from Fisher Scientific. The
primary antibodies, calcium binding protein Rabbit-a-S100 and
Mouse-a-S100b were obtained from Abcam while low-affinity
neurotrophin receptor Rabbit-a-p75 was obtained from Promega.
The secondary antibodies, Donkey-a-Mouse-Cy3 and Donkey-
a-Rabbit-Cy3 were purchased from ImmunoResearch while DAPI
(40,6-diamidino-2-phenylindole) was obtained from Invitrogen.
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2.2.1. Fabrication of gelatin nerve conduits
In this study, a combination of molding and thermally induced
phase separation (TIPS) techniques was used to fabricate three
conduits with different microstructures. With TIPS, preparation
of several different microstructures was accomplished while mold-
ing allowed obtaining 3D shape of the conduits. In the TIPS tech-
nique, demixing is usually stimulated by either loading the
solution below a binodal solubility curve or exposure of the solu-
tion to an immiscible solvent [69]. Therefore, temperature and
solvent/non-solvent ratios are important parameters to obtain
phase separation and different microstructures. The strategy here
was to fix the phase separation temperature and gelation concen-
tration at 20 C and 5%, respectively and change the solvent/non-
solvent ratio in order to obtain different microstructured conduits.
The type of conduits prepared, their solvent/non-solvent ratio and
phase separation temperature are indicated in Table 1.
To create conduits, the mold was first assembled by inserting a
long Teflon capillary (2.0 mm in diameter) into a Teflon tube
(3.8 mm in diameter) (Supplementary Information Figure S.1). As
different from the commercially available single lumen nerve guid-
ance conduits, the diameter and size of these conduits can easily be
adjusted through changing the dimensions of the mold capillary
and tube providing the flexibility to obtain conduits with different
dimensions by preserving their original microstructure. 5% (w/v)
gelatin solutions were prepared at 55 C by dissolving gelatin in
70/30 (v/v) water/ethanol for NF, 85/15 (v/v) water/ethanol for
MP and water for LL conduit. Then, gelatin solution was injected
into the mold and was kept at -20 C for phase separation for 5 h
and incubated in cold ethanol (18 C) overnight. Following the
incubation, the capillary and conduit were removed from the mold
and the samples were immersed in nonsolvent, 1, 4-dioxane, for
2 days and freeze-dried for 3 days. In this process, nonsolvent etha-
nol was used to exchange water (solvent) from the system and
detach conduits from the mold while nonsolvent 1,4 dioxane was
used to stabilize obtained structures during lyophilization. It is
known that nonsolvent must possess relatively high melting tem-
perature to avoid melting during lyophilization, allow facile
removal of sublimation and keep nanofiber structure [70]. 1-
ethyl-3-(3-dimethyl-aminopropyl) carbodiimide HCl (EDC) with
N-hydroxy-succinimide (NHS) were used as cross-linkers of gelatin
conduits with NHS to EDC molar ratio of 0.2. The reaction was car-
ried out in (2-(N-morpholino) ethanesulfonicacid) hydrate (MES)
buffer (pH 5.3, 0.05 M) at 4 C for 24 h. After the cross-linking reac-
tion, conduits were washed with distilled water at 37 C for 3
times. Acetone/water with a ratio of 90/10 (v/v) was used instead
of pure water to protect the nanofibrous structure [71]. Next, con-
duits were frozen at 18 C for 12 h, freeze-dried for 2 days and
stored in a desiccator for later use.2.2.2. Characterization of nerve conduits
The morphology of conduits was examined by scanning elec-
tron microscopy (SEM) on a Philips XL-30SFG model. The samplesTable 1
The type of the conduits prepared, solvent/non-solvent ratio and phase separation
temperature.
Type of Conduit Solvent/Non-solvent
Ratio
Phase Separation
Temperature
Nanofibrous (NF) 70/30 (v/v) Water/
Ethanol
20 C
Macroporous
(MP)
85/15 (v/v) Water/
Ethanol
20 C
Ladder Like (LL) 100% Water 20 Cwere coated with gold using a Magnetron Sputter Coating
Instrument.
Pore sizes of the conduits were measured by using ImageJ soft-
ware while the porosities, e, were calculated using Eq. (1) where Dp
is the skeletal density of gelatin conduit, and Do is the density of
gelatin. For gelatin type B (from calf skin, approx. 225 Bloom),
D0 = 1.35 g/cm3 [62].
e ¼ 1 Dp=Do ð1ÞDp ¼m=V ð2Þ
where m is measured mass (weight) of conduit and V is volume of
conduit determined from the diameter and height of the conduits.
The swelling ratio (SR) of the conduits was also evaluated. Prior
to the swelling study, the dry conduit samples were cut into 1 cm
lengths and weighed. Then, they were immersed into 3 mL of phos-
phate buffer saline (PBS) at pH 7.4 and incubated at 37 C for 24 h.
After incubation, the samples were removed from PBS, blotted with
Kim-wipes to remove excess water from the conduit surfaces and
weighed. The swelling degree (SR) was calculated as:
SR ¼Wdry Wwet
Wdry
 100
where Wdry and Wwet are the sample weights before and after swel-
ling, respectively.
The mechanical properties of conduits were determined on an
Ares-G2 rheometer (TA Instruments) as described elsewhere [66].
The 2 cm length cylindrical conduits, previously immersed in PBS
at 37 C for 24 h, were placed between two parallel stainless steel
plates with a 10 mm gap at 37 C. A dynamic strain sweep test
(with amplitudes ranging between 0.01% and 10%) was conducted
at a frequency of 1 Hz to measure the dynamic shear modulus and
detect the linear viscoelastic region for the conduits. Following the
detection of the linear viscoelastic region, a dynamic frequency
sweep test (with frequency ranging between 0.01 Hz and 10 Hz)
was carried out at a fixed strain in linear viscoelastic region to
measure the dependence of the dynamic shear modulus and the
loss factor on frequency. The storage modulus (G0) and the loss
modulus (G00) were obtained from the measurements as a function
of the strain amplitude or the frequency. The complex modulus
magnitude (G⁄), which is a measure of stiffness (|G⁄|2 = (G0)2 +
(G00)2), and the loss factor (tan d  (G00)/(G0), which is a measure
of internal energy dissipation, were also determined as a function
of the strain amplitude or the frequency. The same test on the con-
duits was conducted after incubation in cell culture media at 37 C
under 5% CO2 atmosphere during 15 days in order to test the
mechanical stability.2.2.3. Cell culture
Brown Norway rat MSCs isolated as described in our previous
work [19] were grown in maintenance medium (MM) composed
of minimum essential medium (a-MEM, Gibco BRL) supplemented
with 20% fetal bovine serum (FBS; Atlanta Biologicals), 4 mM L-
glutamine (Gibco), and antibiotic-antimycotic (Invitrogen) and
incubated at 37 C and 5% CO2 environment. Sub-culturing was
conducted every 2–3 days when the cells reached 80% confluency
as described previously [19]. The cells on passage number two
were used for transdifferentiation experiments. In the experi-
ments, XenoFree cell culture medium that is completely free from
human and animal-derived components was not used since the
focus of this study is to provide the in vitro proof of concept. How-
ever, in future experiments, the possible use of XenoFree cell cul-
ture medium can be explored before the in vivo and clinical studies.
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2.2.4.1. Transdifferentiation procedure. In vitro chemical transdiffer-
entiation of rat MSCs into SC-like phenotypes was performed by
following the previously mentioned protocols [19,27]. Rat MSCs
were grown in MM for 1–2 days in T75 flasks at 37 C and 5%
CO2 atmosphere. Once the cells reached 60–70% confluency, the
MM media was replaced with transdifferentiation media-1
(TDM-1) containing a-MEM supplemented with 1 mM b-
mercaptoethanol (BME; Sigma Aldrich, St. Louis, MO, USA) and
incubated for one day at 37 C and 5% CO2 atmosphere. TDM-1
was then replaced with TDM-2 containing a-MEM, 10% FBS and
35 ng/mL all-trans-retinoic acid (ATRA; Sigma) and incubated in
TDM-2 for 3 days at 37 C under 5% CO2 atmosphere. Following
3 days of incubation, TDM-2 was replaced by TDM-3 containing
a-MEM, 10% FBS, 5 mM forskolin (FSK; EMD Millipore, Billerica,
MA, USA), 5 ng/mL platelet derived growth factor (PDGF; Sigma),
10 ng/mL basic fibroblast growth factor (bFGF, Promega Corpora-
tion, Madison, WI, USA) and 200 ng/mL heregulin b1 (HRG; Cal-
biochem, EMD Millipore) and incubated at 37 C under 5% CO2
atmosphere for 8 days. Cells were washed with PBS prior to each
media change.
2.2.4.2. Immunocytochemical (ICC) analysis. At the end of the trans-
differentiation procedure, the undifferentiated (uMSCs) control
cells and transdifferentiated (tMSCs-2D) cells, possessing SC-like
phenotype, were seeded into 96-well plates (2000 cells/well) and
immunocytochemical (ICC) analysis was applied to characterize
the uMSCs and tMSCs-2D. During the ICC analysis, the cells in
the 96-well plates were rinsed with PBS and fixed with 4%
paraformaldehyde for 20 min at room temperature. The cells were
then rinsed with PBS 3 times and incubated in blocking buffer
composed of 5% normal donkey serum (NDS, Jackson ImmunoRe-
search, West Grove, PA, USA), 0.4% bovine serum albumin (BSA;
Sigma) and 0.2% Triton X-100 (Fisher Scientific) in PBS for one
hour. Several antibodies including glial cell markers, calcium bind-
ing protein Rabbit-a-S100, Mouse-a-S100b (Abcam-ab11178),
low-affinity neurotrophin receptor Rabbit-a-p75 (Promega-
G3231) and Neuron-specific class III beta-tubulin, Mouse-a-Tuj1,
were used for ICC analysis. Following the incubation in blocking
buffer, the cells were further incubated with primary antibodies
at 4C overnight. On the following day, the cells were rinsed with
PBS for 4 times and subsequently incubated in corresponding
secondary antibodies, Donkey-a-Mouse-Cy3 (1:500, Jackson
ImmunoResearch), Donkey-a-Rabbit-Cy3 (1:500, Jackson
ImmunoResearch), and DAPI (40,6-diamidino-2-phenylindole)
(1:2000, Invitrogen) for nuclei staining, all diluted in the same
blocking solution. The cells were incubated for 90 min in the dark
at room temperature and then rinsed with PBS for 3 times before
the fluorescence microscopy imaging.
2.2.4.3. Effect of 3D conduits on cell morphology, proliferation,
spreading and interconnection. The effect of different 3D conduits
on their ability to impact cell morphology, proliferation, spreading
and formation of interconnections was examined. The following
differentiation paradigms were compared: 1) tMSCs-2D (previ-
ously transdifferentiated into SC like phenotype in a T75 flask)
and 2) uMSCs (undifferentiated MSCs) growing in different 3D
gelatin conduits. Cells growing on standard 2D tissue culture poly-
styrene plates (2D TCPS) served as the control condition. The
tMSCs-2D and uMSCs were seeded in the lumen of each conduit
(LL, MP and NF) with a cell density of 1  104 cell/cm2. The 20 mL
of concentrated cell suspension (2  105 cells per 100 mL) was
injected directly into the conduit lumen and incubated 3–5 min
for the integration of the cells into the conduit structure. During
this step, the cells diffused into the conduit microstructure through
the continuous pore network starting from the inner lumen of theconduits. This procedure was repeated 5 times (until all the cell
suspension was absorbed by the conduits) to ensure that cells dis-
perse within the 3D conduit structure and inner lumen rather than
adhering to the wells or outside of the conduits. Then, the cells
were allowed to attach to the conduit microstructure for 6 h before
transferring the conduit to a well in a 6-well plate filled with cul-
ture media. After 1 and 5 days of growth, the samples were
immunolabeled with the Mouse-a-Tuj1 antibody (see above) and
co-labeled with Rhodamine Phalloidin to detect the cellular mor-
phology, proliferation, spreading and interconnection within the
3D conduits.
2.2.4.4. Effect of 3D conduits on mesenchymal stem cell transdiffer-
entiation. The uMSCs were seeded in the lumen of each conduit
(LL, MP and NF) with a cell density of 1  104 cell/cm2 as men-
tioned in Section 2.2.4.3 to test the performance of the developed
3D conduits on cell transdifferentiation. To compare the efficacy
of 3D environment versus the 2D, the same density of cells were
also seeded in 2D tissue culture polystyrene (2D TCPS) 6-well
plates as controls and the same transdifferentiation protocol was
applied. The cells (uMSCs) transdifferentiated in 2D TCPS plates
and T-75 flasks were mentioned as tMSCs-2D. The same chemical
transdifferentiation procedure and ICC analysis described above
were applied to evaluate the differentiation behavior of cells on
different substrates. The cells (uMSCs) directly transdifferentiated
within 3D gelatin conduits possessing different microstructures
were mentioned as tMSCs, while the uMSCs transdifferentiated
in T75 flasks and 2D TCPS plates were mentioned as tMSCs-2D
throughout the text. At the end of the ICC analysis, the 3D conduits
with tMSCs were cut into thin slices in cross-section and mounted
onto glass slides for fluorescence microscopy imaging in order to
observe the cells present not only on the inner lumen of the con-
duits but also within the 3D conduit microstructure. After the col-
lection of images, the number of cells immunostained with the SCs
markers were counted with respect to the total number of cells
(based on DAPI-stained nuclei) in the images to calculate the per-
centage of immunostained cells.
2.2.5. Paracrine activity of tMSCs
The neurotropic factor secreting capacity of tMSCs differenti-
ated in each of the 3D conduits (LL, MP and NF) were evaluated
by measuring released NGF, BDNF and GDNF over a 15 day period.
For this purpose, uMSCs (density of 1  104 cell/cm2) were seeded
in the lumen of each conduit and the transdifferentiation proce-
dure, described above, was applied. The same procedure was also
applied for the same cell density of uMSCs seeded on a 2D TCPS
6-well plate as control. At the end of the transdifferentiation pro-
cess, the tMSCs present in the lumen of conduits and 2D TCPS 6-
well plate were incubated in 3 mLMM at 37 C under 5% CO2 atmo-
sphere for 15 days. The MMwas collected every three days and the
released NGF, BDNF and GDNF amounts were detected through
corresponding ELISA kits (Abcam Rat Beta NGF ELISA kit
ab100757 and Promega BDNF and GDNF Emax ImmunoAssay
Systems) by following the manufacturer’s protocol. At the end of
15 days, the cell viability of the present tMSCs was also evaluated
through CellTiter 96 non-reactive proliferation assay (Promega) by
following the manufacturer’s procedure.
The bioactivity of the secreted neurotrophic factors from tMSCs
present in the conduit lumen was also evaluated using PC12 cells.
PC12 cells were grown in RPMI-1640 media supplemented with
10% horse serum (HS) and 5% FBS at 37 C under 5% CO2 atmo-
sphere and sub-cultured every two days. After reaching 70–80%
confluency, the PC12 cells (density of 1  104 cell/cm2) were har-
vested and seeded on mouse laminin coated 6-well plates and
incubated at 37 C under 5% CO2 atmosphere for 24 h. Then, the
conduits bearing tMSCs (density of 1  104 cell/cm2) within the
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swell inserts Product #3412). The inserts were placed above PC12
cells seeded in 6-well plates containing 3 mL of co-culture media
composed of 70% PC12 cell culture media (RPMI-1640 supple-
mented with 10% HS and 5% FBS) and 30% of MM. The tMSCs in
conduits and PC12 cells were co-cultured for 72 h at 37 C under
5% CO2 atmosphere. At the end of this incubation, the inserts were
removed and the neurite extension of PC12 cells were visualized
under fluorescence microscopy after ICC analysis using primary
antibody Tuj1 and secondary Alexa Fluor 488 (1:1000, Molecular
Probes-Life Technologies, Carlsbad, CA, USA). The quantitative
imaging of all the PC12 cells was conducted using an ImageXpress
Micro high content imaging system (Molecular Devices) and length
of neurites for various conditions was quantified using the neurite
outgrowth module of MetaXpress software (Molecular Devices) as
mentioned in our previous studies [19,72].2.2.6. Statistical analysis
Throughout this study, the significant differences between the
groups were evaluated using ANOVA analysis by Tukey’s method
with 95% confidence interval. The results are presented as aver-
age ± standard deviation calculated from at least three indepen-
dent experiments.3. Results
3.1. The morphology, microstructure and mechanical properties of
conduits
The general appearance of conduits was observed to be similar
as represented in Figure S.1. in Supplementary Information. MP
and LL conduits were transparent while in contact with water
whereas NF conduits had an opaque white color and non-
transparent nature. In the production of NF conduits, phase separa-
tion occurred in the spinodal decomposition region in which the
polymer (gelatin) and solvent-nonsolvent (water-ethanol) mixture
was initially miscible. In this region, a second phase grew sponta-
neously, without thermodynamic or energetic barriers [73], there-
fore producing more intense phase separation and completely
interconnected continuous nanopores. The NF conduits
(Fig. 1A–C) prepared with the water/ethanol ratio of 70/30 (v/v)
have nanofibers with 774.8 nm in length and 187.7 nm in diame-
ter, which mimic the natural ECMwith the fiber diameter changing
between 50 and 500 nm [62]. The increase in solvent nonsolvent
ratio from 70/30 (v/v) to 85/15 (v/v) promoted polymer-solvent
(gelatin-water) interaction resulting in loss of nanofiber
microstructure and formation of macroporous microstructure as
liquid-liquid phase separation occurred (Fig. 1C-D). The closed
pore structures were the result of another phase separation mech-
anism in which polymer-lean phase disperses in the matrix of
polymer-rich phase by nucleation and growth [59]. When pure
water was used as solvent instead of water/ethanol mixture, a
ladder-like microstructure was achieved (Fig. 1G–I).
Average pore size of the conduits measured from SEM pictures
along with their porosities and swelling ratios are shown in Fig. 2.
The percent porosity of the NF conduits was found slightly higher
( 95%), while their pore sizes were significantly lower (100 mm
for MP and 150 mm for LL) than those of MP and LL conduits. It
was observed that the change in the microstructure, porosity and
pore size of the conduits significantly affected their water swelling
capacity (Fig. 2A and B). As illustrated in Fig. 2B, the change in
structure from nano-fibrous (NF) to ladder-like (LL) resulted in a
significant increase in swelling ratio. This is due to presence of
large pores in the lumen of conduit and throughout the cross-
section which can allow effective diffusion of water and absorbmore water [74]. This result suggests that the increase in pore size
was the determining factor in the swelling capacity of the conduits
rather than the porosity, since percent porosities of the conduits
were very close to each other. The swelling ratios of MP and LL con-
duits were found similar in addition to their pore sizes and percent
porosities (Fig. 2A and B).
At water/ethanol ratio of 70/30 (v/v), liquid-liquid phase sepa-
ration occurred at phase separation temperature higher than the
freezing point of the polymer solvent mixture causing the forma-
tion of small pores with a high porosity. As the freezing point of
the polymer solvent mixture approaches the phase separation
temperature with an increase in water/ethanol ratio, the liquid-
liquid phase separation leads to formation of larger pores with
lower porosity as in the case of MP conduits. The microstructure
observed in LL conduits is a consequence of the solid-liquid phase
separation, where polymer solution quenches below the freezing
point of the solvent, producing a porous and channeled structure.
When the temperature of the polymer solution is lower than the
freezing point of the solvent, the crystallization of the solvent takes
place and the polymer phase is expelled from the crystallization
fronts as impurities. A continuous polymer-rich phase with pores
and channels is formed by aggregation of polymer expelled from
every single solvent crystal [67]. The direction of channels in the
structure is parallel to the direction of heat transfer. This technique
has been used in guided regeneration applications, such as scaf-
folds for spinal cord injury [75,76] and transplantation sheets for
retina [77–79], but has never been applied for MSCs differentiation
into SC like phenotype.
It was previously reported that not only intrinsic factors, but
also extrinsic and effective mechanical factors have a strong influ-
ence on the regulation of stem cell fate [80]. In most of the recent
studies, the influence of effective storage, loss and complex moduli
on the cell fate were also investigated and compared [66,81–86].
Considering these studies, we used rheometry under similar condi-
tions for the measurement of effective moduli in order to demon-
strate the effect of storage moduli on stem cell fate. The
microstructure of the conduits (porosity, pore size and swelling
ratio) affected their mechanical properties of the conduits. All of
the conduits, regardless of the microstructural differences, dis-
played an elastic behavior with storage modulus (G0) higher than
the loss modulus (G00) as shown in Fig. 3A and B. In addition, the
G0 and G00 values remained independent of the strain amplitude
for each conduit confirming the linear viscoelastic behavior
(Fig. 3A). The NF conduits possessed the highest G0 and G00 values
sequentially, followed by MP and LL conduits due to their lower
mesh size with stronger fibrous network (Fig. 1A–C) compared to
MP and LL conduits. Pore size and connectivity of the pores are
the primary factors controlling the mechanical properties of the
conduits.
The average complex modulus (G⁄), which is a measure of the
stiffness, and the loss factor (tan d), which is a measure of the inter-
nal energy dissipation, were calculated and tabulated in Table 2
along with the storage (G0) and loss modulus (G00) at constant fre-
quency and percent strain. The storage modulus (G0) showed the
dominant contribution to G⁄, since G0 value was higher than the
G00 in all conduits, verifying that the conduits indeed displayed
elastic behavior. NF conduits showed the highest G⁄ values indicat-
ing a stiffer nature than that of MP and LL conduits with sequen-
tially smaller G⁄ values. This result simply illustrated that
although all of the conduits displayed elastic behavior, their rela-
tive stiffness changed with the microstructure. The stiffest conduit
with the highest G⁄ value (NF) had the smallest pore size and swel-
ling capacity (Fig. 2A and B), which is in accordance with findings
in the literature [87]. All three conduits showed tand values
between 0 and 1, exhibiting solid-like behavior at physiological
temperatures. Overall, these conduits maintained their integrity
Fig. 1. SEM images of conduits fabricated with different solvent/nonsolvent ratios. (A–C) NF conduit with 70/30 (v/v) water/ethanol, (D–F) MP conduits with 85/15 (v/v)
water/ethanol and (G–I) LL conduits with 100% water. Images C, F and I represent the inner lumen pore structure of each conduit.
Fig. 2. Average pore size, percent porosity (A) and swelling ratio (B) of the conduits. * Represents statistically insignificant difference of MP and LL conduits in percent porosity
and swelling ratio. Similarly, ** represents statistically insignificant difference of MP and LL conduits in pore size (p > 0.05). In all cases, NF is significantly different from MP
and LL conduits.
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tuning their properties (pore size, swelling ratio and stiffness/elas-
ticity) to control the growth and function of the cells. Moreover,the conduits did not show a significant reduction in the storage
and loss modulus after incubation in cell culture media for 15 days
(Fig. 2.S.). Apart from these properties, the elastic behavior along
Fig. 3. Evolution of the storage (G0) and loss (G00) moduli, as a function of (A) percent strain and (B) frequency for prepared conduits. (p < 0.05).
Table 2
Storage (G0), loss (G00) modulus, loss factor (tan d) and complex modulus (G*) evaluated at a frequency of 0.1 Hz, using 0.1% strain and at 37 C for the fabricated conduits. Same
letters represent statistically insignificant differences (p > 0.05).
G0  106 (Pa) G00  106 (Pa) tan d G*  106 (Pa)
NF 7.80 ± 0.19 1.86 ± 0.98b 0.24 ± 0.12c 8.06 ± 0.38
MP 3.89 ± 2.50a 1.30 ± 0.83b 0.33 ± 0.05c 4.10 ± 2.6d
LL 0.38 ± 0.12a 0.32 ± 0.05 0.22 ± 0.15c 0.40 ± 0.13d
a Represents the G0 values that are not significantly different for MP and LL conduits but significantly higher for NF conduits.
b Represents the G00 values that are not significantly different for NF and MP conduits but significantly lower for LL conduits.
c Represents that tan d values that do not change significantly with respect to conduit type.
d Represents the G* values that are not significantly different for MP and LL conduits but are significantly higher for NF conduits.
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sion upon hydration, provides these conduits easy handling during
the surgical procedures [88,89].
3.2. Morphology, proliferation, spreading and viability of MSCs in
different conduits
It is well known that there are differences in morphology and
behavior when cells are cultured in 2D versus 3D matrices [65].
Considering the dynamic nature of the ECM microenvironment,
cell culture experiments carried out in 2D are limited in their abil-
ity to investigate and define natural cellular features such as mor-
phology, proliferation, spreading, differentiation, activation of
signaling pathways and ultimately cell behavior [65]. Therefore,
the additional dimensionality that the cells experience in 3D is a
powerful approach to control cell features and behavior in artificial
matrices mimicking the ECM. The tMSCs-2D (MSCs previously
transdifferentiated into SC like phenotype in a T75 flask) and
uMSCs (undifferentiated MSCs) were grown on conduits with dif-
ferent 3D microstructures and on 2D TCPS plates to observe cellu-
lar behavior in different matrices (Fig. 4.). At the end of day 1 and 5,
the cells in MP, LL conduits and 2D TCPS plates were stained and
imaged using fluorescence microscopy, whereas the cells in NF
conduits were visualized under SEM due to their opaque nature
preventing the imaging with fluorescence microscopy. It was
observed that both tMSCs-2D and uMSCs initially attached and
proliferated on the conduits and 2D TCPS plates at the end of the
first day. Although the initial cell plating density was the same
for all substrates (1  104 cell/cm2) and cell types, cells showed a
higher attachment tendency towards the 2D TCPS plates, showing
more cells compared to their 3D gelatin conduit counterparts at
the first day (Fig. 4.). However, at the end of 5 days, the number
of cells on the 2D TCPS plates were considerably lower than that
on the 3D MP and LL conduits for both tMSCs-2D and uMSCs, while
the number of cells on NF conduits were similar to the 2D TCPS
plates, indicating a difference in substrate dependent cell prolifer-
ation. In addition, both tMSCs-2D and uMSCs in MP and LLconduits exhibited a higher degree of cell spreading and the forma-
tion of interconnected cellular networks within the 3D conduit
structure at the end of 5 days as compared to NF conduits and
2D TCPS plates. This was likely due to the higher complex moduli
(G⁄), and thus the higher stiffness and smaller pore sizes (Figs. 2
and 3 and Table 2) of the NF conduits and 2D TCPS plates, resulting
in a denser matrix surrounding the cells. Large pores can allow
effective diffusion and absorption of cells and cell culture media.
Therefore conduits with larger pores (such as MP or LL) can retain
more cells and culture medium in their microstructure as well as
allowing more space to grow, than conduits with smaller pores,
such as NP conduits [74]. Consequently, the cells were observed
to slow their proliferation which may likely be due to limitations
associated with space and greater cell-cell contact inhibition in
NF conduits and 2D TCPS plates [90]. This is also in accordance
with some recent studies involving other cell types, which
reported hydrogel stiffness dependent proliferation and spreading
of fibroblast and muscle cells [90–92]. For instance, Bott [90] noted
the decreasing proliferation and spreading of fibroblast cells with
increasing material stiffness in the MMP-degradable PEG hydrogels
suggesting that cells need to remodel their pericellular and extra-
cellular environment in order to effectively spread and proliferate.
The MP and LL conduits prepared in this study with relatively
smaller complex moduli (G⁄) values and significantly larger pores
compared to NF conduits provided an available microenvironment
for the cells to spread and proliferate resulting in higher number of
cells at the end of 5 days. The results suggest that cell proliferation,
cell spreading and their ability to form interconnected cellular 3D
networks were enhanced in the conduits with low G⁄ values and
large pore sizes (MP and LL conduits) consistent with the literature
[80,93–95]. The tMSCs-2D possessed heterogeneous morphologies,
bearing multipolar, spindle as well as fibroblastic shapes and
showed better proliferation while uMSCs had a round and
fibroblastic-like morphology with relatively limited proliferation
in the conduits. Although the higher proliferation rate of tMSCs-
2D than uMSCs was contradictory to our previous findings [19]
on 2D cell culture plates, this difference may be attributed to the
Fig. 4. Morphology, cell proliferation, spreading and interconnection of tMSCs-2D (previously transdifferentiated into SC like phenotype in a T75 flask) and uMSCs
(undifferentiated MSCs) growing in different 3D gelatin conduit microstructures and standard 2D tissue culture polystyrene plates (2D TCPS). The cells on NF conduits were
visualized by SEM images since fluorescence imaging was difficult due to opaqueness of the sample. Initial cell plating density: 1  104 cell/cm2. Blue: DAPI staining for
nucleus and Red: Rhodamine Phalloidin staining for actin filaments.
Fig. 5. Cell viability of tMSCs-2D (previously transdifferentiated into SC like
phenotype in a T75 flask) and uMSCs (undifferentiated MSCs) seeded in different 3D
gelatin conduits at the end of 15 days incubation. Initial cell density: 1  104 cell/
cm2 (p < 0.05).
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enhancing the spreading and proliferation of tMSCs-2D. In accor-
dance with our findings, previously published data also reported
increased cell proliferation and spreading in 3D matrices with low-
ered material stiffness [65,66,80,90]. Overall the results show that
the conduits prepared in this study with adjustable microstructure,
pore size and stiffness are promising materials mimicking the ECM
microenvironment for the MSCs.
The number of viable cells after 15 days of incubation in 3D
conduits and 2D TCPS plates were also determined for both
tMSCs-2D and uMSCs (Fig. 5.). Both cell types showed the least
number of viable cells on NF conduits possessing the stiffest nature
with highest G⁄ value, while MP and LL conduits with relatively
less stiffness and larger pores provided a more conducive environ-
ment for cell growth and survival. Therefore, the number of cells
within 3D MP and LL conduits almost doubled in 15 days. These
results are in accordance with the observations represented in
Fig. 4.
3.3. Transdifferentiation of MSCs into SC like phenotypes in different
conduits
The structural and mechanical properties of scaffolds affect the
differentiation characteristics of the MSCs as they significantly
alter cell morphology, spreading and proliferation. To examine
the direct effect of microstructural and mechanical scaffold proper-
ties on transdifferentiation behavior, the undifferentiated MSCs
(uMSCs) were seeded and transdifferentiated on 3D gelatin con-duits and 2D TCPS plates (as controls). The tMSCs grown and trans-
differentiated in 3D conduits were characterized and compared
with the cells transdifferentiated on 2D TCPS plates and control
uMSCs by immunostaining using glial markers such as a-S100,
a-S100b and a-p75 used to identify SCs (Fig. 6) [96]. A common
glial marker, GFAP, was not selected for the tests based on our pre-
vious data indicating no detectable GFAP expression in tMSCs [19].
As before, the transdifferentiation of uMSCs within NF conduits
Fig. 6. Differentiation of uMSCs into tMSCs in 3D conduits and tMSCs-2D on 2D tissue culture polystyrene (TCPS) plate. uMSCs in 2D TCPS was used as control. Glial cell
markers, p75, s100 and s100b, staining with Red: Cy3 and Blue: DAPI. Cell density: 1  104 cell/cm2. The Rhodamine Phalloidin staining was also performed on tMSCs 15 days
after transdifferentiation in 3D conduits.
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opaque nature of the conduit. The visualization and degree of
immunostaining of selected markers across MP, LL conduits and
2D TCPS plate controls were presented in Fig. 6 for tMSCs,
tMSCs-2D and uMSCs. The results for 2D TCPS plate substrates
shown in Fig. 6 revealed that anti-S100b showed no detectable
immunolabeling of the uMSCs while anti-p75 antibodies immuno-
labeled very few uMSCs compared to tMSCs-2D on 2D TCPS plates.
The reason for p-75 immunostaining of uMSCs was due to occa-
sional nuclear staining while it was cytoplasmic for transdifferen-
tiated MSCs [19]. Because of this reason, the cytoplasmic anti-p75
staining of cells were taken into account [19]. In addition, although
not very effective as in the case of transdifferentiated MSCs, anti-
S100 immunolabeling was also observed for the uMSCs on 2D TCPS
plates. Compared to the uMSCs, the tMSCs-2D on 2D TCPS plates
showed a significant degree of immunostaining of SC markers with
more than 85% of cell staining indicating successful transdifferen-
tiation (Fig. 6). The cells transdifferentiated in MP and LL conduits
also showed a high degree of immunolabeling indicating the suit-
ability of the conduits for transdifferentiation as well. More than
85% of the cells in LL conduits showed efficient labeling for all
selected markers. The immunolabeling of the cells in MP conduits
were 65% for p75, 75% for S100 and 85% for S100b markers.
This difference could be attributed to the microstructural and
mechanical differences between MP and LL conduits, with MP hav-
ing slightly smaller pore size and stiffer nature compared to LL con-
duits, (Figs. 2, 3 and Table 2) limiting the differentiation of the
cells. Although, the degree of immunolabeling is slightly lower in
MP conduits than that of 2D TCPS plate controls, our overall results
of differentiating uMSCs into tMSCs directly in 3D gelatin conduits
are competitive with our previous reports indicating the MSCtransdifferentiation in T75 flasks [19]. In addition, our reported
immunolabeling percentages (85% of the cells in LL for all markers
and 65% for p75, 75% for S100 and 85% for S100b markers in
MP) are highly consistent with the values reported in the literature
despite the different conditions. For instance, Ladak [97] quantified
MSC marker expression as 51% GFAP, 47% S100 and 45% NGFR
upon the MSC differentiation into Schwann-like cells in T-75 flasks
using the modified protocol from Dezawa [27], demonstrating
heterogeneous differentiation of approximately 50% of cells pre-
sent in culture which is considerably lower than what we observed
in 3D conduits [97]. Following the transdifferentiation of uMSCs in
the MP and LL conduits into tMSCs, the cells were kept in their
respective environment for another 15 days and it was observed
that uMSCs directly transdifferentiated in MP and LL conduits con-
tinued to proliferate and spread within this period (Fig. 6). Overall
our results showed that the 3D gelatin conduits with different
microstructures and mechanical properties not only successfully
mimic the ECM for proliferation and spreading, but also provide
a convenient environment for cell transdifferentiation.
3.4. Paracrine activity of tMSCs and uMSCs grown in different 3D
conduits
Schwann cells are capable of secreting certain neurotrophic fac-
tors, such as NGF, GDNF and BDNF, during injury leading to forma-
tion of diffusion gradients and activation of intracellular signal
transduction pathways that enhance regenerating axon growth
and neuron survival [17,98,99]. The differentiated MSCs possessing
SC-like phenotype were also capable of secreting neurotrophic fac-
tors and the degree of secretion changes depending on the
microstructural and mechanical properties of the scaffold.
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considered another measure of cell differentiation. As such, ELISAs
were conducted to determine the amount of NGF, GDNF and BDNF,
secreted from the tMSCs differentiated in NF, MP and LL 3D gelatin
conduits as well as tMSCs-2D in the 2D TCPS control plates (Fig. 7).
The secretion of NGF and GDNF in all types of conduits and 2D
TCPS plates were higher in tMSCs than the uMSCs as expected
whereas BDNF release was not detected from either of the cell
types. The NGF release from uMSCs in different conduits was not
found to be significantly different (Fig. 7A) on the other hand, the
NGF, secreted from tMSCs, varied depending on the conduit
microstructure. The tMSCs differentiated in LL conduits showed
the highest NGF secretion (2.5 pg/mL per cell) whereas those in
NF showed the lowest NGF secretion (0.8 pg/mL per cell). The
highest NGF release in the LL conduits may be attributed to its
microstructure with favorable porosity, pore size and elasticity
(Figs. 1–3 and Table 2) enabling a higher degree of transdifferenti-
ation and number of viable cells (Figs. 4–6), significantly enhancing
NGF secretion capability. Although the porosity, pore size and
swelling ratio of MP and LL conduits were found to be close to each
other, the NGF secretion capacity of the tMSCs in MP conduits were
significantly smaller than that of LL conduits (Fig. 7A). This may be
due to the slightly stiffer nature of MP conduits (Table 2) which
actually lowered cell viability and degree of transdifferentiation
(Figs. 5 and 6). The amount of NGF released from tMSCs in NF con-
duits was even lower than the 2D TCPS plates, which was due to
the inefficient differentiation and fewer number of cells present
in the NF conduit as shown in Figs. 4 and 5. The stiff nature, small
pore size and low swelling ratio of NF conduits (Figs. 1–3) pre-
vented cellular attachment and differentiation leading to insignif-
icant paracrine activity. The overall GDNF release from the tMSCs
was lower than the NGF release regardless of the conduit type
(Fig. 7B). The tMSCs in MP and LL conduits secreted significantly
higher amount of GDNF than that from NF conduits and 2D TCPS
plates. In all cases, the GDNF or NGF amount released from the
uMSCs were significantly lower compared to the amounts secreted
from tMSCs (Fig. 7B.).
In order to investigate the biological activity of the released NGF
and GDNF from the tMSCs differentiated in various 3D conduits
and 2D TCPS plates, a co-culture experiment with PC12 cells was
conducted and the results of neurite extension in PC12 cells trig-
gered by the secreted NGF and GDNF were represented in Table 3
and Figure S.3. in Supplementary Information. The tMSCs differen-
tiated in LL conduits triggered the greatest neurite extension in
PC12 cells, which was followed by MP conduits, 2D TCPS plates
and NF conduits (Table 3). This trend was consistent with the neu-
rotrophic factor secreting capacity of the tMSC-differentiated con-
duits illustrated in Fig. 7. We did not observe any significantFig. 7. Paracrine activity of tMSCs differentiated in 3D conduits and on 2D TCPS and uMS
per cell. Initial cell density: 1  104 cell/cm2. Incubation time 15 days. No BDNF relea
insignificant difference (p > 0.05).enhancement in neurite extension of the PC12 cells in contact with
the uMSCs in conduits regardless of the conduit type (Table 3).
4. Discussion
Cell-based nerve regeneration therapies (including autologous
or allogeneic cells) are being investigated as important strategies
for the treatment of large peripheral nerve injuries. Autologous
cell-based treatment has been considered as a promising approach
for the repair of peripheral nerve injuries in the clinic, particularly
for chronic injuries, because they pose little risk of immunological
rejection. However, it is difficult to obtain sufficient quantities of
healthy cells with high activity from every patient. Furthermore,
cell extraction is time-consuming, making it difficult to use them
promptly to treat acute diseases [41,100–102]. In contrast, allo-
geneic cell-based treatment is readily available and can be admin-
istered immediately to treat acute injuries. In addition, obtaining
allogeneic cells from young healthy donors is a reasonable
approach with advantages of quality assurance, reduced time and
cost. However, the allogeneic cell-based treatment has been
reported to possess the risk of immunological rejection [41,100–
102]. Regardless of the pros and cons of each treatment approach,
an appropriate conduit system is required for efficient cell trans-
plantation and nerve regeneration. Therefore, in this study,
gelatin-based 3D porous conduits with different microstructures
and mechanical properties were fabricated using combined mold-
ing and TIPS techniques. These conduits can be used in the trans-
plantation of both autologous and allogeneic cells to treat acute
or chronic injuries. The ease of TIPS technique in the preparation
of different microstructures as opposed to difficulties in electro-
spinning and self-assembly techniques [67,68] to achieve 3D struc-
tures and its cost effectiveness makes our strategy favorable and a
promising alternative for 3D conduit production intended for neu-
ral tissue engineering.
Significant data regarding differentiation and behavior of stem
cells from different sources have been obtained from cells cultured
on regular 2D tissue culture plate surfaces [103]. However, lack of
one dimension in 2D substrates biases the true differentiation
behavior or potential of stem cells pointing out the need for 3D
scaffolds mimicking the complex microenvironment to achieve
more reliable information [65,95]. Therefore, to address this issue
we have successfully created 3D structures in gelatin conduits in
order to examine cell differentiation. Most of the studies in the lit-
erature used MSCs that had already been transdifferentiated in
regular 2D cell culture environments for transplantation purposes
[16,17,20,21], whereas, in this study, the transdifferentiation of
MSCs was performed directly within the developed 3D gelatin con-
duits with different microstructures and mechanical properties.Cs seeded in 3D conduits and on 2D TCPS. Released amount of (A) NGF and (B) GDNF
se was observed in any of the conditions above. The letters ‘‘a–e” represent the
Table 3
Bioactivity of NGF and GDNF secreted from tMSCs differentiated in NF, MP, LL conduits and 2D TCPS plates against PC12 cells neurite extension. uMSCs in NF, MP and LL conduits
and 2D TCPS plate were used as control. PC12 cells density: 1  104 cell/cm2. tMSCs cell density in conduits: 1  104 cell/cm2. Incubation time: 72 h. (p < 0.05).
Cell Type Neurite Length per Cell (mm)
NF MP LL 2D TCPS
tMSC 2.00 ± 0.58 4.40 ± 0.25 9.80 ± 0.67 3.90 ± 0.47
uMSC 1.50 ± 0.45 2.30 ± 0.58 1.70 ± 0.80 1.60 ± 0.93
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the differentiation as well as morphology, proliferation and spread-
ing behavior of the cells in different 3D environments, but also led
to the reduction in differentiation steps, cost, effort and time
[85,104–106], while enhancing the bioactivity of the transplanted
cells in promoting neurite outgrowth. The studies investigating
the effect of various conduit structure and mechanical properties
on differentiation of MSC from different sources (adipose tissue,
placenta, umbilical cord blood etc.) were mostly focused on the
osteogenic differentiation [86,107–109], however, to the best of
our knowledge there is no other study reporting the influence of
these properties on transdifferentiation of bone marrow-derived
MSCs into SC-like phenotypes.
Our results indicated that the change in solvent/non-solvent
ratio controlled the structural and mechanical properties of the
developed 3D gelatin conduits (Figs. 1–3 and Table 2) which in
turn determined cellular behaviors such as morphology, prolifera-
tion, spreading and differentiation (Figs. 4–7 and Table 3). It was
previously reported that the elasticity of human tissues varies
depending on the site (brain (E = 0.1–1 kPa), muscle (E = 8–
17 kPa), skin (E = 10–103 kPa) and bone (E = 106–107 kPa)) [110].
Our values of complex modulus (G⁄) were found to vary between
0.27  103 and 8.44  103 kPa depending on the conduit
microstructure (Table 2), which showed that the fabricated con-
duits were in high stiffness range. According to previous reports
on 2D substrates, high material stiffness promoted cell attachment
[111], proliferation [90], spreading [90,112], morphology [113],
and migration [114]. Although NF conduits had high stiffness and
porosity, the presence of small pores in 3D structure decreased
the available space and prevented the attachment and proliferation
of cells. On the other hand, the MP and LL conduits, exhibiting
softer nature with larger pore sizes compared to NF conduits, both
provided required stiffness and a favorable microenvironment for
substantial cellular attachment, proliferation and spreading. In
addition, the 3D structure of these conduits can contribute to the
recruitment of proteins to adhesion sites which may also facilitate
proliferation and spreading [115–117]. Consequently, the prolifer-
ation and spreading capacity of the MSCs in the heterogeneous and
anisotropic 3D structures of our conduits contributed to neural
differentiation.
Previous studies have shown that the matrix stiffness regulates
the differentiation of MSCs into specific lineages. For instance, Eng-
ler [110] observed neurogenic differentiation on soft substrates
with elasticities ranging between 0.1 and 2 kPa. Lanniel [118]
found that MSCs on soft hydrogels displaying 6.5 kPa elasticity
expressed neuronal morphologies and neural markers, whereas
those cells growing on stiffer matrices (41 kPa) expressed osteo-
genic markers. Although our conduits have a stiff nature (ranging
between 0.27  106 and 8.44  106 Pa), our results indicated that
they were capable of supporting neurogenic differentiation. This
could be due to the large pores within the 3D structure enabling
efficient changes in cell proliferation, spreading and morphology
leading to differentiation. Indeed, the SC like differentiation of
MSCs on our conduits was expected since these cells had already
been successfully transdifferentiated into SC-like phenotypes on
regular 2D TCPS plates [16,17,19,27] with significantly stiffer nat-
ure than our conduits. Neuronal differentiation potential in stiff3D conduit structures was also reported by previous studies
[56,65,119]. In addition to the matrix stiffness, the intrinsic
mechanical properties of MSCs may also contribute to their differ-
entiation ability into SC-like phenotype [80]. Stiff single cells, such
as bone marrow derived MSC with the elastic moduli of 3.2 kPa
[120], have been effectively differentiated into various lineages in
stiff conduits as in our case. Although it has been demonstrated
that matrix elasticity affects MSC differentiation, the mechanism
has not yet been clearly delineated. It was previously reported that
matrix stiffness may trigger multiple signaling pathways through
mechanotransduction and mechanosensors including integrins
[121], ion channels [122], cell adhesion [123], actin cytoskeleton
[124], and surface receptors [125]. Among those pathways, we
anticipated that differentiation of MSCs was modulated by block-
ing of the BMP/Smad signaling pathway, which promotes integrin
internalization, enhancing bone morphogenetic protein receptors
(BMPR) endocytosis and neuronal gene expression [62,126]. We
reported significant neurotrophic factor release from the MSCs dif-
ferentiated in the fabricated 3D conduits (ranging between 1 and
3 pg/mL per cell of NGF and 0.35 to 0.7 pg/mL per cell of GDNF)
and their biological activity against PC12 cells (neurite outgrowth
ranging from 2 to 10 mm per cell). Brohlin [127] reported
0.01 pg/mL per cell of BDNF release along with relatively smaller
amounts of NGF and GDNF upon bone marrow-derived MSCs dif-
ferentiation on regular 2D TCPS plates using very similar transdif-
ferentiation protocol. Their results indicated that differentiation of
MSCs resulted in upregulation of BDNF (0.01 pg/mL per cell), ele-
vating its secretion, while the levels of NGF and GDNF remained
same and lower than BDNF [127]. Compared to this study,
although we did not detect any significant BDNF secretion, our
NGF and GDNF secretion capacity per cell, particularly in MP and
LL conduits was significantly higher illustrating the advantage of
3D structure with appropriate stiffness and pore size for efficient
transdifferentiation. The neurotrophic factors released from tMSCs
in 3D conduits (with cell density of 1  104 cell/cm2) showed sig-
nificant bioactivity against PC12 cells by inducing neurite exten-
sion of 2–10 mm/cell (Table 3). Other studies conducted with 2D
TCPS plates have shown similar bioactivity against dorsal root gan-
glia and spinal motor neurons, causing neurite extensions of
0.1 mm/cell with 75,000 tMSCs/mL [16,127] and neurite exten-
sion of 2 mm/cell with 5000 MSCs/cm2 [128], respectively.
Despite the differences in initial tMSC seeding density and target
cells, our results were found comparable with the findings in the
literature in terms of biological and paracrine activity indicating
the promoting effect of 3D gelatin conduits (especially MP and
LL) and their variable microstructure and mechanical properties.5. Conclusion
3D gelatin conduits with different microstructures were suc-
cessfully fabricated with a combined molding and TIPS technique
through changing solvent/non-solvent ratios. This strategy offers
an easy and cost effective way to fabricate gelatin-based 3D con-
duits with various microstructures providing advantages over cur-
rently used electrospinning and self-assembly techniques. The
microstructural (pore size ranging between 5 and 150 mm) and
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8.44  106 Pa) of the conduits significantly influenced the cellular
behavior and differentiation. The stiff nature of 3D conduits, along
with the right pore size and microstructure, enhanced MSC attach-
ment, proliferation, spreading with high numbers of viable cells
and differentiation. In contrast to some reports indicating that
softer matrices promote neural differentiation while stiffer ones
enhance osteogenic differentiation, our results emphasized that
highly porous, large pore sized stiff matrices were also capable of
supporting MSC differentiation into SC-like phenotypes. The direct
transdifferentiation of MSCs within the 3D conduit matrices sup-
ported neurotrophic factor secretion, showing significant bioactiv-
ity on PC12 cells neurite outgrowth. Both neurotrophic factor
secretion capacity and bioactivity of the tMSCs in 3D gelatin con-
duits were found to be significantly higher than that of their 2D
and 3D counterparts. Overall, it can be concluded that 3D conduits
prepared in this study showed promising results for neural regen-
eration applications. In addition, the proper elastic behavior of the
conduits coupled with the stiffness characteristics, transparent
nature and expansion upon hydration enable easy handling for
the surgical procedures. In conclusion, the in vivo performance of
these conduits should be tested.Acknowledgments
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